angiotensin-i and chrysin

Uganda was affected by two major waves of coronavirus disease 2019 (COVID-19). The first wave during late 2020 and the second wave in late April 2021. This study compared epidemiologic characteristics of hospitalized (HP) and non-hospitalized patients (NHP) with COVID-19 during the two waves of COVID-19 in Uganda.. Wave 1 was defined as November-December 2020, and Wave 2 was defined as April-June 2021. In total, 800 patients were included in this study. Medical record data were collected for HP (200 for each wave). Contact information was retrieved for NHP who had polymerase-chain-reaction-confirmed COVID-19 (200 for each wave) from laboratory records; these patients were interviewed by telephone.. Demographic and epidemiologic characteristics of HP and NHP differed between and within Waves 1 and 2 of COVID-19 in Uganda.

Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cyprinidae; DNA Damage; Flavonoids; Fresh Water; Fructose; Gills; Insecticides; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Rats; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Water; Water Pollutants, Chemical